Formosa Laboratories, Inc. (4746.TW)
TWD 71.9
(-0.96%)
TWD 71.9
(-0.96%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 1.05 TWD | -41.67% |
| 2022 | 1.80 TWD | -83.52% |
| 2021 | 10.92 TWD | 188.89% |
| 2020 | 3.78 TWD | 1021.95% |
| 2019 | -0.41 TWD | -123.03% |
| 2018 | 1.78 TWD | -32.06% |
| 2017 | 2.62 TWD | -52.19% |
| 2016 | 5.48 TWD | 65.56% |
| 2015 | 3.31 TWD | 6.77% |
| 2014 | 3.10 TWD | 419.59% |
| 2013 | -0.97 TWD | -1315.54% |
| 2012 | 0.08 TWD | -97.68% |
| 2011 | 3.44 TWD | -13.78% |
| 2010 | 3.99 TWD | 0.0% |
| 2009 | - TWD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -0.82 TWD | -153.95% |
| 2024 Q2 | 2.36 TWD | 387.8% |
| 2023 FY | - TWD | -41.67% |
| 2023 Q4 | 1.52 TWD | 260.0% |
| 2023 Q3 | -0.95 TWD | -237.68% |
| 2023 Q2 | 0.69 TWD | 221.05% |
| 2023 Q1 | -0.57 TWD | -121.03% |
| 2022 Q3 | 4.09 TWD | 1097.56% |
| 2022 Q1 | -3.78 TWD | -157.14% |
| 2022 FY | - TWD | -83.52% |
| 2022 Q4 | 2.71 TWD | -33.74% |
| 2022 Q2 | -0.41 TWD | 89.15% |
| 2021 Q3 | -3.20 TWD | -146.65% |
| 2021 Q2 | 6.86 TWD | -30.28% |
| 2021 FY | - TWD | 188.89% |
| 2021 Q1 | 9.84 TWD | 900.0% |
| 2021 Q4 | -1.47 TWD | 54.06% |
| 2020 Q2 | 4.99 TWD | 584.47% |
| 2020 Q3 | 0.93 TWD | -81.36% |
| 2020 FY | - TWD | 1021.95% |
| 2020 Q1 | -1.03 TWD | -39.19% |
| 2020 Q4 | -1.23 TWD | -232.26% |
| 2019 Q2 | -1.20 TWD | -475.0% |
| 2019 Q1 | 0.32 TWD | -69.52% |
| 2019 Q4 | -0.74 TWD | -142.53% |
| 2019 Q3 | 1.74 TWD | 245.0% |
| 2019 FY | - TWD | -123.03% |
| 2018 Q1 | 1.83 TWD | 490.32% |
| 2018 Q3 | -1.28 TWD | -541.38% |
| 2018 Q4 | 1.05 TWD | 182.03% |
| 2018 FY | - TWD | -32.06% |
| 2018 Q2 | 0.29 TWD | -84.15% |
| 2017 Q3 | 0.42 TWD | -68.66% |
| 2017 Q2 | 1.34 TWD | 131.03% |
| 2017 Q1 | 0.58 TWD | -62.09% |
| 2017 FY | - TWD | -52.19% |
| 2017 Q4 | 0.31 TWD | -26.19% |
| 2016 Q2 | 1.67 TWD | 40.34% |
| 2016 FY | - TWD | 65.56% |
| 2016 Q3 | 1.09 TWD | -34.73% |
| 2016 Q1 | 1.19 TWD | -7.75% |
| 2016 Q4 | 1.53 TWD | 40.37% |
| 2015 Q4 | 1.29 TWD | -3.73% |
| 2015 Q2 | 0.20 TWD | -59.18% |
| 2015 Q1 | 0.49 TWD | -28.99% |
| 2015 Q3 | 1.34 TWD | 570.0% |
| 2015 FY | - TWD | 6.77% |
| 2014 Q1 | 0.66 TWD | -1.49% |
| 2014 FY | - TWD | 419.59% |
| 2014 Q4 | 0.69 TWD | -34.91% |
| 2014 Q3 | 1.06 TWD | 51.43% |
| 2014 Q2 | 0.70 TWD | 6.06% |
| 2013 Q4 | 0.67 TWD | 6.35% |
| 2013 Q1 | -2.45 TWD | -665.63% |
| 2013 Q2 | 0.03 TWD | 101.22% |
| 2013 FY | - TWD | -1315.54% |
| 2013 Q3 | 0.63 TWD | 2007.02% |
| 2012 Q2 | 0.33 TWD | -2.94% |
| 2012 Q1 | 0.34 TWD | -56.41% |
| 2012 Q3 | -0.30 TWD | -190.91% |
| 2012 Q4 | -0.32 TWD | -6.67% |
| 2012 FY | - TWD | -97.68% |
| 2011 Q1 | 1.04 TWD | -72.56% |
| 2011 Q4 | 0.78 TWD | -17.02% |
| 2011 Q2 | 0.70 TWD | -32.69% |
| 2011 Q3 | 0.94 TWD | 34.29% |
| 2011 FY | - TWD | -13.78% |
| 2010 Q4 | 3.79 TWD | 0.0% |
| 2010 Q1 | - TWD | 0.0% |
| 2010 Q2 | - TWD | 0.0% |
| 2010 FY | - TWD | 0.0% |
| 2010 Q3 | - TWD | 0.0% |
| 2009 FY | - TWD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Grape King Bio Ltd | 9.81 TWD | 89.297% |
| Standard Chem & Pharm CO., LTD. | 4.67 TWD | 77.516% |
| Maywufa Company Ltd. | 1.27 TWD | 17.323% |
| ScinoPharm Taiwan, Ltd. | 0.36 TWD | -191.667% |
| Lotus Pharmaceutical Co., Ltd. | 15.72 TWD | 93.321% |
| LIWANLI Innovation Co., Ltd. | 0.06 TWD | -1558.768% |
| YungShin Global Holding Corporation | 3.11 TWD | 66.238% |
| PhytoHealth Corporation | -0.24 TWD | 537.5% |
| SCI Pharmtech, Inc. | 2.70 TWD | 61.111% |
| PharmaEssentia Corporation | -1.93 TWD | 154.404% |
| Bora Pharmaceuticals Co., LTD. | 30.20 TWD | 96.523% |